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StrokeAbstract Introduction: Fever is common in patients with acute stroke, and mostly it is due to
infectious complications. The neurologic effects of fever are signiﬁcant, increased temperature in
the post-injury period has been associated with increased cytokine activity and increased infarct size.
Aim: To test the hypothesis that fever and increased serum procalcitonin are associated with poor
outcomes after neurological injury.
Methodology: Fifty patients (30 males (60%) and 20 females (40%) mean 43.8 ± 11.7 years) were
divided into two groups: Group I: 25 traumatic patients (i.e., head injury) and Group II: 25 non-
traumatic patients (i.e., stroke). Temperature was measured from admission until the patients were
discharged or died, and PCT was measured on day 1 of admission and after 48 h of admission.
Results: Fever has been associated with poor outcome, as fever is linked to worse GCS scores
(12.6 ± 1.2 vs. 7.7 ± 2.6 in patients with fever, P 0.001), longer MV durations (3.6 ± 1.0 vs.
22.4 ± 9.1 days, in patients with fever, P 0.001), longer ICU length of stay (8.1 ± 4.7 vs.
23.0 ± 8.0 days in patients with fever, P 0.001) and increased mortality (P= 0.001). There were sig-
niﬁcantly higher PCT levels in the mortality group versus the survived group at day 1 (4.15 ± 0.82
vs. 2.47 ± 0.059 ng/ml, respectively, P 0.0001) and after 48 h of admission (5.20 ± 1.14 vs.
3.19 ± 0.092 ng/ml, respectively, P 0.0001).
Conclusion: Fever had a strong link to worse GCS, longerMV durations, increased length of ICU
stay, higher mortality rates and worse overall outcomes in neurocritical patients. High PCT levels
can predict mortality in those patients.
 2015 The Egyptian College of Critical Care Physicians. Production and hosting by Elsevier B.V. All
rights reserved.1. Introduction
Fever is a common condition in patients with stroke and other
brain injuries. Hyperthermia appears to correlate with poor
outcome in these patients, although a direct causative link
has not been established yet. After controlling for illness
2 A. Feasal et al.severity, diagnosis, age, and complications, fever has been
found to be strongly associated with increased lengths of inten-
sive care unit (ICU) and hospital stays, a higher mortality rate
and worse overall outcomes [1,2].
Sometimes fever in stroke patients is due to infectious com-
plications. In some patients with acute stroke and fever, the
infection source cannot be identiﬁed. In some of these cases
where fever exists without an obvious infection source, fever
does not respond to empirical antibiotic treatment and is
thought to be due to a central nervous system lesion. The pres-
ence of fever, in general, in patients with acute stroke has been
associated with poor outcomes [3].
The neurologic effects of fever are signiﬁcant as increased
temperature in the post-injury period has been associated
with increased local cytokine activity, increased infarct size,
and poorer outcomes in the acute phase of injury. This is,
in part, related to the fact that patients at risk of intracra-
nial hypertension may be signiﬁcantly affected by an
increase in temperature because the intracranial blood vol-
ume increases with fever. This reduces compliance and puts
the brain at risk for further injury. Hyperthermia, when high
enough (>43 C), has been reported to cause neuronal
injury in normal brain, and lengthy periods of moderate
(40 C) hyperthermia have been reported to alter brain struc-
ture and function [4].
Additionally, traumatic brain injury (TBI) patients are at
risk for secondary injury from fever because for every 1 C
increase in core temperature, there is a 5–7% increase in the
metabolic rate. This taxes the stressed energy reserves of these
severely brain injured catabolic patients. The higher metabolic
demand of fever exacerbates this problem and can lead to
additional muscle and fat store losses [5].
In TBI patients procalcitonin (PCT) increased only moder-
ately in most patients and peaked at days 1, 2 after trauma,
and the concentrations rapidly decline thereafter.
Complications, such as sepsis, infection, blood transfusion,
prolonged intensive care unit treatment, and poor outcomes
were more frequent in patients with initially high PCT levels
(>1 ng/ml) [6].
Traumatic brain injury patients are especially prone to
develop complications such as infections and sepsis. Because
clinical symptoms and conventional markers are not always
reliable signs for sepsis and infection diagnoses; therefore,
biomarkers such as PCT are often used as a diagnostic tool
in these patients. However, similar to patients undergoing elec-
tive surgery, an increase of PCT during the early postoperative
or post-traumatic period may occur independent of the sepsis
or infection diagnoses [6].
Inﬂammatory response is also a principal early component
in the pathophysiology of stroke. Serum PCT, a marker of sep-
ticaemia and infection severity, has also been proposed as an
indicator of systemic inﬂammatory response in noninfectious
situations in these patients [7].2. Aim of the work
The purpose of this study was to test the hypothesis that fever
and increased serum PCT are associated with poor outcomes
after neurological injury.3. Patients and methods
3.1. Patients
Study was conducted on 50 acute neurological insult patients
(30 males and 20 females) that were admitted to the neurocrit-
ical unit at Cairo University between January 2012 and
September 2012.
3.1.1. Patients were divided into two equally large groups
 Group I: 25 patients (traumatic patients, e.g., head injury).
 3 pts with diffuse axonal injury.
 5 pts with concussion.
 4 pts with cerebral contusion.
 2 pts with cerebral haemorrhage.
 2 pts with fracture base of skull.
 4 pts with subdural haemorrhage.
 3 pts subarachnoid haemorrhage.
 2 pts intracerebral haemorrhage.
 Group II: 25 patients (non-traumatic patients, e.g., stroke).
 14 pts with thrombotic stroke.
 4 pts with embolic stroke.
 7 pts with haemorrhagic stroke.3.1.2. Exclusion criteria
 Sepsis patients.
 Septic shock patients.
 Chronically ill patients.
 Patients with known hyper-bilirubinemia (>0.4 mg/ml) or
hypertriglyceridemia (>10 g/I). We excluded pts with
hyper-bilirubinemia and hypertriglyceridemia due to possi-
ble interference with PCT measurement.3.1.3. All patients were subjected to the following
1. History evaluation.
2. Clinical examination.
3. Glasgow coma scale assessment.
4. Body temperature measurement.
5. PCT level measurement.
6. Intensive care unit duration (in days) assessment.
7. Mechanical ventilation (MV) duration (in days)
assessment.3.2. Methods
Body temperature was measured in the axillary region with a
medical thermometer. We deﬁned ICU fever as body tempera-
ture above 38 C. Body temperature was measured daily from
day 1 of admission until patient discharge or death.
3.3. Procalcitonin measurements
We measured PCT on day 1 of admission (PCT1) and 48 h
after admission (PCT2).
Table 1 Ages for both groups.
Group No. of pts Mean ± SD P
Group I 25 39.93 ± 8.82 Non-signiﬁcant
Group II 25 45.45 ± 12.55
Table 2 GCS values for both group.
Group Mean ± SD P value
GCS Group I 12.33 ± 1.17 0.0001
Group II 7.31 ± 2.45
Table 3 Need for MV in both groups.
Group No. of pts P value
MV Group I 5 0.0001
Group II 23
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Figure 2 Mechanical ventilation durations for both groups.
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Two to three millilitres of whole blood was collected from the
patients and transported to the laboratory in an icebox. These
samples are known to be stable regarding PCT for one week in
a 2–8 C refrigerator. The serum PCT levels were evaluated
with an enzyme-linked immunosorbent assay (ELISA). A
serum separator tube (SST) was used to allow the samples to
clot for two hours at room temperature or overnight at 4 C
before centrifugation for 15 min at 1000g. The serum samples
were then removed and assayed immediately or were aliquoted
and stored at 20 C or 80 C. Repeated freeze–thaw cycles
were avoided.
3.5. The statistical methods
Data were statistically described in terms of mean ± stan-
dard deviation (SD), frequencies (case numbers) and percent-
ages when appropriate. Numerical variable comparisons
between the study groups were conducted using a Student’s t
test for independent samples. For comparing categorical data,
a Chi square (v2) test was performed. Correlation between var-
ious variables was determined using a Spearman rank correla-
tion equation for normal variables. P values less than 0.05
were considered statistically signiﬁcant. All statistical calcula-
tions were performed using Microsoft Excel 2007 (Microsoft
Corporation, NY, USA) and SPSS (Statistical Package for
the Social Science; SPSS Inc., Chicago, IL, USA) version 15
for Microsoft Windows.
4. Results
Our study was conducted on 30 males (60%) and 20 females
(40%) with a mean age of 43.8 ± 11.7 years, a minimum age
of 17 and maximum age of 76 years.0 
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Figure 1 Gender distribu4.1. Demographic data
4.1.1. Age distribution
There was no statistically signiﬁcant difference between the
two groups with regard to age, as shown in Table 1.
4.1.2. Gender distribution
There was no statistically signiﬁcant difference between the
two patient groups regarding gender (P= 0.15), as shown in
Fig. 1.
4.1.3. Glasgow coma scale (GCS)
There was a statistically signiﬁcant difference between the two
patient groups regarding the GCS values (P= 0.0001), as
shown in Table 2.Group II
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Figure 3 Mortality in both groups.
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Figure 4 Mortality in patients who needed MV assistance.
Table 4 Body temperature for both groups.
High temperature (>38 C) Group No. of pts P value
Group I 15 0.0001
Group II 23
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5.1. Need for mechanical ventilation
Twenty-eight of our patients needed MV assistance through-
out their ICU stay. There was a statistically signiﬁcant differ-
ence between the two patient groups regarding the need for
MV (P= 0.0001), as shown in Table 3.
5.2. Duration of mechanical ventilation
A statistically signiﬁcant shorter MV day period in group I
compared with group II patients was found (10.96 + 10.47
vs. 24.84 + 6.96 days, respectively, P= 0.0001), as shown in
Fig. 2.5.3. Mortality
Thirty-ﬁve patients died. There was a signiﬁcantly higher mor-
tality rate among the group II patients compared with group I
(P= 0.001), as shown in Fig. 3.
5.4. The relation between MV and mortality
Twenty-eight patients of the 35 patients who died had needed
MV assistance while none of the patients that survived needed
MV assistance (P= 0.0001), as shown in Fig. 4.
6. Body temperature
There was a statistically signiﬁcant difference between groups I
and II with regard to body temperature (P= 0.0001), as
shown in Table 4.
6.1. Fever in relation to GCS, MV and length of ICU stay
Fever has been associated with poor outcomes, and fever was
linked to more worse GCS values (12.6 ± 1.2 vs. 7.7 ± 2.6 in
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Figure 5 Fever in relation to GCS.
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Figure 6 Fever in relation to MV and length of ICU stay.
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Figure 7 Fever in relation to mortality.
Impact of body temperature and serum procalcitonin on critically ill neurological patients 5patients with fever, P= 0.001), longer MV durations (3.6 ±
1.0 vs. 22.4 ± 9.1 days, in patients with fever, P= 0.001),
and longer ICU stays (8.1 ± 4.7 vs. 23.0 ± 8.0 days,
in patients with fever, P= 0.001), as shown in Fig. 5
(see Fig. 6).6.2. Fever in relation to mortality
All mortality patients had elevated body temperatures
compared with three out of the 15 patients who survived
(P= 0.0001), as shown in Fig. 7.
6 A. Feasal et al.7. Procalcitonin levels (PCT1, PCT2)
There were signiﬁcantly higher PCT levels in group II com-
pared with group I at PCT1 and PCT2 (P= 0.0001), as shown
in Table 5.
There were signiﬁcantly higher PCT levels in the mortality
versus the survived group at PCT1 and PCT2 (P= 0.0001), as
shown in Table 6.
7.1. PCT1 and PCT2 cut-off point analyses for mortality
predictions
PCT1 at cut off to 3.32 ng/ml was found to be 79.4% sensitive
and 100% speciﬁc for mortality prediction with a 100% posi-
tive predictive value, a 68.2% negative predictive value and an
AUC of 95.7%.
Conversely, PCT2 at a 3.54 ng/ml cutoff point was found to
have a sensitivity of 91.4% and a speciﬁcity of 73.3% for mor-
tality predictions with a 88.6% positive predictive value, a
78.6% negative predictive value and an AUC of 0.91, as shown
in Fig. 8.
7.2. Correlation between body temperature and PCT
Body temperature was correlated with PCT1 (R value 0.685
and P value <0.001) and PCT2 (R value 0.683 and P value
<0.001).
7.3. Discussion
Fever is a common condition in stroke and other types of brain
injury, and previous research has shown a strong link to
increased length of ICU and hospital stay, higher mortality
rates, and worse overall outcome [8].
Traumatic brain injury (TBI) patients frequently experience
febrile episodes that may be of infectious or non-infectious ori-
gins. Neurogenic fever (NF) is a non-infectious source of fever
in TBI patients. Until recently, NF was thought to be a rela-
tively rare consequence of TBI, but other studies have reported
that 4–37% of TBI survivors experience this sequelae [9].Table 5 Procalcitonin levels in both groups.
Group PCT Mean ± SD P value
Group I PCT 1 (ng/ml) 2.8 ± 0.7 0.0001
PCT 2 (ng/ml) 3.4 ± 0.7
Group II PCT 1 (ng/ml) 4.4 ± 0.7
PCT 2 (ng/ml) 5.8 ± 0.7
Table 6 PCT levels in the mortality versus survived groups.
Mean + SD P value
PCT1 (ng/ml) No mortality 2.47 ± 0.59 0.0001
Mortality 4.15 ± 0.82
PCT2 (ng/ml) No mortality 3.19 ± 0.92 0.0001
Mortality 5.20 ± 1.14Neurogenic fever results from a disruption in the hypotha-
lamic thermostat, which results in an abnormal increase in
body temperature [10].
The neurologic effects of fever are signiﬁcant, as increased
temperature in the post-injury period has been associated with
increased local cytokine activity, increased infarct size, and
worse outcomes in the acute phase of injury. This is, in part,
related to the fact that patients at risk of intracranial hyperten-
sion may be signiﬁcantly affected by rises in temperature
because the intracranial blood volume increases with tempera-
ture. This reduces compliance and puts the brain at risk for
further injury. Hyperthermia, when high enough (>43 C),
has been reported to cause neuronal injury in normal brain,
and lengthy periods of moderate (40 C) hyperthermia have
been reported to alter brain structure and functioning.
Neurogenic fever may be associated with the presence of pro-
longed unawareness or a coma state [4].
In our studied patients, group I (traumatic patients) had
better GCS values than group II (stroke patients) and this
translated to a higher need for MV assistance in group II
(twenty-three out of twenty-eight patients needed MV).
Thirty-ﬁve of our patients died, and there was a higher
mortality rate among the group II patients (23 out of 25
patients vs. 12 out of 25 patients in group I, P= 0.001).
In our attempt to separate patients with fever due to infec-
tion from those with fever and no infection (fever of a central
origin), we found that the only factor that was predictive of a
central origin fever was earlier fever onset because an
incubation period for an infection to develop would not be
needed. However, some overlap between the two groups was
expected.
In our study, we found that fever onsets that happened in
the ﬁrst 2 days of hospitalization occurred in 64% of the feb-
rile patients. These rates are similar to those described by
Hindfelt in 1976, while Przelomski et al. in 1986 and Terent
and Anderson in 1981 described a lower fever incidence.
Comparisons among various studies are difﬁcult, however,
because of the differences in the fever deﬁnitions and measure-
ments. Considering death within 30 days after hospital admis-
sion as the main measure of outcome, we found that fever was
conﬁrmed to be signiﬁcantly related to a poorer outcome;
however, it was not possible to estimate a threshold above
which fever seemed detrimental [11–13].
Similar to our study, several studies measured fever over
the entire ICU stay duration so that patients with a longer stay
had a greater chance of fever being identiﬁed. However, several
studies found a signiﬁcant association between outcomes in
patients with stroke and body temperature measured on
admission, suggesting that the relationship between longer
ICU stays and fever cannot be attributed solely to treatment
effects [14–18].
In our study, fever occurred in 76% of patients and the
mortality rate in these patients was more than 90%. This result
is higher than the result obtained in a study by Kilpatrick and
colleagues in 2000 [19] who found that fever occurred in 47%
of their observed patients. Additionally, other studies [11–13]
showed that fever occurred in up to 20–30% of patients.
Moreover, after haemorrhagic stroke, fever has been reported
in 40–50% of patients. And the high mortality rate in our
study can be explained by a higher infection rate in our
patients (64%) compared with this study, which had a 50%
infection rate.
PCT1 PCT2
Figure 8 ROC curve.
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cance of fever in stroke. In one study, Hindfelt found that a
mean body temperature above 37.5 C from any cause in the
ﬁrst 7 days was associated with a poor prognosis at 2 months
after the stroke. However, his study was retrospective, the
sample excluded patients who died within 2 months, and the
outcome measurement was not validated; therefore, his con-
clusions are not easily generalized to the whole stroke patient
population [11].
In a prospective study of 281 patients with stroke, Terent
and Andersson found that in patients with a mean body tem-
perature of 38 C or more during the ﬁrst week, chest X-ray
ﬁlms revealed bronchopneumonia in half. Fever indicated a
signiﬁcantly worse prognosis [13].
Przelomski et al. [12] prospectively investigated the fre-
quency and causes of fever in a sample of 104 consecutive
stroke patients. In particular, these authors studied the possi-
ble association between fever and it was almost always sec-
ondary to infections and the lesion size. A comparison with
our study is difﬁcult because the authors excluded brain stem
infarcts and intraventricular haemorrhage, conditions in which
‘‘neurogenic fever’’ is most likely, and they did not evaluate the
prognostic value of fever.
High fever thus seemed to be associated with a higher prob-
ability of early death, whereby it was shown that fever of at
least 37.9 C indicated poor early prognosis even without a
consideration of its causes. Because the majority of the exper-
imental studies documented the direct effects of temperature
on neurological damage, our data suggest that fever could
worsen prognosis through direct neurological damage.
In patients with multiple traumas, the PCT level provides
information because only moderate amounts of PCT are
induced, and higher concentrations correlate with a more sev-
ere trauma and a higher frequency of various complications,
including sepsis and infection. Most importantly, the moderate
trauma-related increase of PCT and the rapidly declining con-
centrations provide a baseline value near to the normal range
[6].
The effects of haemorrhagic stroke on PCT are not yet
known. Determining the natural history of PCT in ahaemorrhagic stroke patient would provide beneﬁcial informa-
tion as to whether PCT can be used as a biomarker in this pop-
ulation to help differentiate a bacterial from a non-bacterial
hyperthermia cause [7].
We measured PCT levels (ng/ml) on day one and after 48 h
of admission in order to evaluate the early PCT levels that
occur before the development of an infection. There were sig-
niﬁcantly higher PCT levels in the mortality versus survived
groups at day 1 (P= 0.0001) and after 48 h of admission
(P= 0.0001).
Our results are in agreement with a study by O’Connor E
et al. in 2004 [20] that evaluated PCT and CRP as mortality
markers in 62 patients with TBI and subarachnoid haemor-
rhage and they found that serum PCT appeared to correlate
with TBI severity and mortality.
Our study is also in agreement with a study by Linda et al.
[6]. This was a prospective study that included all admissions
<12 h after TBI where serum PCT and S100B were measured
immunoluminometrically for 5 days. They concluded that PCT
and S100B are useful for mortality predictions in TBI patients.
Our study is not in agreement with the study by Miyakis
et al. in 2004 [7]. They studied the prognostic value of PCT
measured on days 2, 3 and 4 of admission in 30 patients
who were admitted with acute stroke. They found that serial
serum PCT levels did not correlate with stroke mortality or
neurologic outcomes at discharge and this could be explained
by the fact that studies that have correlated laboratory param-
eters with prognoses for acute stroke sometime had conﬂicting
results [21–23].
In general, head trauma patients had good prognoses com-
pared with stroke patients because they had signiﬁcantly fewer
fever instances and lower PCT levels, and this translated into
less mortality in this group.8. Conclusion
Fever has a strong link to worse GCS values, longer MV dura-
tions, increased length of ICU stay, higher mortality and worse
overall outcomes in neurocritical patients. High PCT levels can
8 A. Feasal et al.predict mortality in those patients. Head trauma patients had a
good prognosis compared with stroke patients.
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